Wilkie MJ - Search Results

1

A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer.

Sachse C, Smith G, Wilkie MJ, Barrett JH, Waxman R, Sullivan F, Forman D, Bishop DT, Wolf CR; Colorectal Cancer Study Group. Sachse C, et al. Among authors: wilkie mj. Carcinogenesis. 2002 Nov;23(11):1839-49. doi: 10.1093/carcin/23.11.1839. Carcinogenesis. 2002. PMID: 12419832

2

Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer.

Smith G, Carey FA, Beattie J, Wilkie MJ, Lightfoot TJ, Coxhead J, Garner RC, Steele RJ, Wolf CR. Smith G, et al. Among authors: wilkie mj. Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9433-8. doi: 10.1073/pnas.122612899. Epub 2002 Jul 1. Proc Natl Acad Sci U S A. 2002. PMID: 12093899 Free PMC article.

3

Melanocortin 1 receptor (MC1R) genotype influences erythemal sensitivity to psoralen-ultraviolet A photochemotherapy.

Smith G, Wilkie MJ, Deeni YY, Farr PM, Ferguson J, Wolf CR, Ibbotson SH. Smith G, et al. Among authors: wilkie mj. Br J Dermatol. 2007 Dec;157(6):1230-4. doi: 10.1111/j.1365-2133.2007.08209.x. Epub 2007 Oct 4. Br J Dermatol. 2007. PMID: 17916200

4

Methylene tetrahydrofolate reductase genotype modifies the chemopreventive effect of folate in colorectal adenoma, but not colorectal cancer.

Lightfoot TJ, Barrett JH, Bishop T, Northwood EL, Smith G, Wilkie MJ, Steele RJ, Carey FA, Key TJ, Wolf R, Forman D. Lightfoot TJ, et al. Among authors: wilkie mj. Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2421-30. doi: 10.1158/1055-9965.EPI-08-0058. Epub 2008 Aug 14. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18703816

5

Polymorphisms in xenobiotic metabolizing enzymes and diet influence colorectal adenoma risk.

Northwood EL, Elliott F, Forman D, Barrett JH, Wilkie MJ, Carey FA, Steele RJ, Wolf R, Bishop T, Smith G. Northwood EL, et al. Among authors: wilkie mj. Pharmacogenet Genomics. 2010 May;20(5):315-26. doi: 10.1097/FPC.0b013e3283395c6a. Pharmacogenet Genomics. 2010. PMID: 20375710

6

A splice site polymorphism in the G-protein beta subunit influences antidepressant efficacy in depression.

Wilkie MJ, Smith D, Reid IC, Day RK, Matthews K, Wolf CR, Blackwood D, Smith G. Wilkie MJ, et al. Pharmacogenet Genomics. 2007 Mar;17(3):207-15. doi: 10.1097/FPC.0b013e32801a3be6. Pharmacogenet Genomics. 2007. PMID: 17460549

7

Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy.

Wilkie MJ, Smith G, Day RK, Matthews K, Smith D, Blackwood D, Reid IC, Wolf CR. Wilkie MJ, et al. Pharmacogenomics J. 2009 Feb;9(1):61-70. doi: 10.1038/sj.tpj.6500491. Epub 2008 Feb 5. Pharmacogenomics J. 2009. PMID: 18253134

8

Identification of a functionally impaired allele of human novel oxidoreductase 1 (NDOR1), NDOR1*1.

Finn RD, Wilkie M, Smith G, Paine MJ. Finn RD, et al. Among authors: wilkie m. Pharmacogenet Genomics. 2005 Jun;15(6):381-6. doi: 10.1097/01213011-200506000-00002. Pharmacogenet Genomics. 2005. PMID: 15900210

9

Can dietary furanocoumarin ingestion enhance the erythemal response during high-dose UVA1 therapy?

Beattie PE, Wilkie MJ, Smith G, Ferguson J, Ibbotson SH. Beattie PE, et al. Among authors: wilkie mj. J Am Acad Dermatol. 2007 Jan;56(1):84-7. doi: 10.1016/j.jaad.2006.07.003. Epub 2006 Sep 14. J Am Acad Dermatol. 2007. PMID: 17097373

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters